Iterum Therapeutics plc — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/37135370-cbd2-4fcc-89de-1d026f86d07a/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-011897 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012694 |
| FY 2019 | $37.0k | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010242 |
| FY 2018 | $869.0k | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-009089 |
| FY 2017 | $508.0k | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-009089 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-009089 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Iterum Therapeutics plc — all facts · Net Income · Operating Income